Try our Advanced Search for more refined results
Life Sciences - November, 2019
258 articles
- NY Appeals Court Rules Against McDermott In Privilege Row
- Insys Verdict Flip Is A Check On Aggressive Feds
- Allergan Hid Breast Implants' Cancer Risk, Women Say
- Teva Slips FCA Suit, Giving DOJ Another Granston Memo Win
- Fed. Circ. Tosses Sleep Mask PTAB Appeal Over Standing
- Coherus, Amgen End Patent War Over Humira Biosimilar
- Where BPCIA Issues Stand As FDA Approves 25th Biosimilar
- Nelson Mullins Nabs 2 IP Attorneys From Mintz
- Tracking 3 Enforcement Trends In Health Care
- Headaches Abound As States Try To Clarify CBD Landscape
- Schools Poised To Open New Front In Opioid MDL
- Brown Rudnick Accused Of Bungling $300M Bankruptcy Claim
- Boston Heart Settles FCA Suit Over Referral Fraud For $26.7M
- True Health's Ch. 11 Plan Confirmed Despite CMS' Protests
- Insys Judge Drops Part Of Landmark Opioid Verdict
- Janssen Can't Use Tenn. Law To Nix $70M Risperdal Verdict
- AbbVie Says AndroGel Suit Should Be Moved To Georgia
- NYC Council Approves Bill To Ban Flavored E-Cigs
- Ex-MiMedx Execs Charged With Cooking Biotech Co.'s Books
- Full Fed. Circ. Won't Rehear ITC E. Coli Patent Row
- Bayer Essure Injury Suits Kicked Back To Pa. State Court
- Weitz & Luxenberg Beats Ex-Client's Appeal Over BMS Case
- FDA Won't Vouch For CBD's Safety In Products
- Fed. Circ. Undoes 'Cryptic' PTAB Ruling In Pfizer Vaccine Row
- Merck Hits Generic Co. With IP Suit Over Diabetes Drug
- Baxter Hit With Stock Drop Suit Over Forex Accounting
- Roche Hit With $137M Verdict For Infringing Lab Test Patents
- Humira Buyers Say They've Proven AbbVie's 'Patent Thicket'
- Boston Scientific Gets Sanctions Nixed In FCA Suit
- CVS Customers Certify NY, Ariz. Classes In Generic Price Suit
- Takeda Wants Immediate Appeal Of Actos Order 'Uncertainty'
- Implant Co.'s Insurer Can Recoup Costs, Nev. Justices Told
- Fla. High Court Won't Hear Challenge To Pot-Growing Ban
- Book Review: Who's To Blame For The Broken Legal System?
- Justices Decline Pfizer's LA Court Fight, Hospital FCA Cases
- 3rd Circ. Sends Fosamax Suits To District Court
- Ferring, Blackstone Ink $570M Bladder Cancer Therapy Deal
- Supreme Court Has 'No Work' To Do On Mayo, Clinic Says
- SEC Expands Ad Fraud Suit Against Outcome Health Execs
- ​​​​​​​​​​​​​​Paul Weiss, S&C Shape $9.7B Novartis Deal For NJ Drugmaker
- IP Firm Faces $10M Malpractice Suit Over Denied Gene Patent
- California Revokes Cannabis Co.'s Licenses After Raid
- Pa. Appeals Court To Rethink J&J's $20M Mesh Verdict Appeal
- Fed. Circ. Backs J&J Unit's Win In Glucose Test Strip IP Suit
- Calif. Pot Markup Will Rise On New Year's Day, Tax Dept. Says
- New Deal Anchors AndroGel Antitrust Suit To Pa., Buyers Say
- Advising Cannabis Cos. As Mich. Legalizes Recreational Use
- How States' 2020 Policy Agendas Are Taking Shape
- The Top Pennsylvania Employment Law Changes In 2019
- J&J Loses 'Premature' Bid To Toss $37.3M Asbestos Verdict
- UK Litigation Roundup: Here's What You Missed In London
- Health Hires: Ropes & Gray, Arnold & Porter
- Dykema Taps Corporate Finance Atty For Chicago Office
- HHS Attys Say High Court Ruling Curbs Billing Enforcement
- Monsanto Can't Ditch LA County's PCB Suit
- Teva Gets PTAB To Review Cushing's Syndrome Drug Patent
- USDA Hemp Rules Pose Problems, Oregon Sens. Say
- Democratic Candidates Advocate For Busting Drug Patents
- Insys Reaches Creditor Deal For Tiered Ch. 11 Recoveries
- PTAB Probes Authenticity Of Prior Art In Pain Treatment Case
- Pharma Co. Wins $16.7M At Trial Over Inflated Ad Costs
- Deals Rumor Mill: Hudson's Bay, Charles Schwab, DoorDash
- House Advances Bills Targeting Pharma IP Practices
- Fed. Circ. Ruling May Affect Eligibility Of Life Sciences Patents
- Disclosure, Transparency Regs Headline DOL Benefits Agenda
- Harvest Health Walks Away From $225M Financing Deal
- Zimmer Must Face Pa. Woman's Faulty Hip Implant Claims
- AbbVie Investors Fight Bid To Toss Humira Kickbacks Suit
- Fund Pays $4M To Settle Mass. Medicare Kickback Probe
- Buyers Chide Endo's Claim That Class Too Small For Cert. Bid
- Hologic Inks $205M Sale Of 'Underperforming' Med Tech Co.
- Senators Press FDA Nominee On Vaping Flavor Ban
- Pa. Justices Reopen Time For 'Thousands' Of Risperdal Suits
- Cancer Treatment Startup Raises $56M In Funding
- House Panel Approves Cannabis Tax, Decriminalization Bill
- House Committee Advances Sweeping Pot Legalization Bill
- Gov. Can't Ban Vapes Via Exec Order, Mass. Top Court Hears
- Urine Maker Owes $900K In Atty Fees After Loss In IP Suit
- Opioid MDL Judge Plots New Bellwether Trials Across US
- Mass. Gov. Defends Vape Ban In 'Time Of Crisis'
- Purdue Gets OK To Pay States' Costs In Opioid-Related Ch. 11
- Direct Buyers Seek Cert. In Zetia Generic Delay Suit
- Full Fed. Circ. Won't Look At Patents For Withholding Meds
- True Health Ch. 11 Plan Draws Feds' Fire Over CMS Claims
- Fed. Circ. Upholds Mylan's PTAB Win On Insulin Drug Lantus
- GreenVision Targets Health Care Acquisition After $50M IPO
- No Full Fed. Circ. Review In Genzyme Cancer Patent Case
- Colo. Judge Skips SEC Insider Trading Deposition
- Health Care Fraud Lessons For Lawyers Advising Doctors
- How To Hire Lateral Partners More Effectively
- Lumenis Nabs $1B Value In Sale To Baring PE Asia
- Lawyers Can Counsel Medical Pot Clients, NY Bar Says
- Jury To Hash Out Insurers' $10M Lightning Strike Claim Row
- GNC Broke Deal With Supplement Maker, Pa. Judge Says
- Retrial Sought Against J&J After FDA Finds Asbestos In Talc
- Roche Says Biotech Co. Wants To Stretch Tech Royalty Rights
- Purdue Opioid Claims Need National Fix, High Court Told
- Calif. AG Sues Juul Over Advertising To Teens
- Wellington Nabs $393M To Invest In Novel Drug Developers
- Judge Caps Insys Exec's 'Astronomical' Nixon Peabody Tab
- US Trustee Says Sackler Ties Bar E&Y From Purdue Ch. 11
- J&J Defeats New Trial Bid In NJ Asbestos-In-Talc Case
- MVP: Cohen Milstein's Sharon K. Robertson
- Supreme Court Won't Hear Martin Shkreli's Appeal
- FTC Clears Bristol-Myers' $74B Celgene Buy With Drug Sale
- RJR, Phillip Morris Owe $157M To Smoker's Widow, Jury Says
- Recently Reversed: How J&J, Avis & LG Toppled Big Verdicts
- Texas Justices To Weigh Reach Of Forum Choice In Deals
- J&J's $572M Opioid Loss Cut To $465M As Judge Fixes Math
- Motley Rice's Joseph Rice On The Opioid MDL And More
- Indivior Can't Duck Opioid Marketing Fraud Indictment
- Oregon Court Blocks State Ban On Flavored Cannabis Vapes
- Purdue Says Paying States' Costs Will Help Ch. 11 Estate
- Opioid Distributors Didn't Cause Nuisance, Pa. Judge Told
- 5 Takeaways As DOJ Finds Footing In FCA Dismissal Crusade
- Retailers Can Split Claims In Loestrin Antitrust Trial
- CBD Retailer Says Dosage Suit Doesn't Show Actual Injury
- FDA Rules For CBD Supplements Urgently Needed, Org Says
- MVP: Steptoe & Johnson's John Molenda
- The Coming Storm Of Biometric Privacy Laws: How To Comply
- Perrigo Investors Win Cert. In Suit Over Thwarted Sale
- Cannabis Lobby Grows As Congress Mellows Out On Pot
- Massachusetts Supreme Court Keeps Vape Ban In Place
- Senators Float Bill To Create Drug-Pricing Agency
- Hospira Infringed 2 Valid Par Adrenalin Patents, Judge Says
- Roche Inks Up To $1.39B Deal For Goodwin-Advised Biotech
- CBD Capsule Case Belongs In State Court, Plaintiff Says
- Insys Alters Ch. 11 Plan After Claimant Deal Falls Through
- Health Care Ad Co. Ex-Executive Faces Fraud Claims
- Mass. Biotech Co. Sues Feds Over Denial Of Visa For Scientist
- 9th Circ. Judge Calls DOJ's Appeal In FCA Suit 'A Mistake'
- Calif. Panel Revives Allergan Worker's Mistaken Firing Suit
- CBD Product Maker Can Refile Libel Suit Against Writer
- Rare HHS Patent Suit May Impact HIV Drug Pricing, Access
- Deals Rumor Mill: Xerox, Thyssenkrupp, Thermo Scientific
- The Coming Storm Of Biometric Privacy Laws: What To Expect
- Retrieval-Masters To Share Data Breach Info With State AGs
- Engaging With International Carcinogen Evaluations
- Michigan Moves Up Recreational Pot Sales To Dec. 1
- MVP: Gibson Dunn's Jane M. Love
- Purdue's Law Firms Must Return Retainers, US Trustee Says
- Galena Again Beats Investors' 'Shotgun' Opioid Claims Suit
- GSK Says Boehringer Spreading Lies About Its Inhalers
- Drug Cos. May Rethink Patent Strategy After Fed. Circ. Ruling
- HHS Beats Suit Over Radioactive Drugs In Medicaid Program
- 3rd Circ. Slams J&J Bid To Out HIV Drug Suit Whistleblowers
- Purdue Claimants Oppose Payment Of Settling States' Costs
- Ex-Immunomedics Brass Must Face Del. Suit Over $250M Deal
- Drugmakers Rip HHS At DC Circ. For Price-Disclosure Rule
- Women Sue Co. Over 'Exorbitantly Priced' Preterm Birth Drug
- MVP: Weil Gotshal's Edward Reines
- Covington Guides Merck In $576M Deal For Life Science Biz
- UBiome Trustee Seeks To Unload Assets By Mid-December
- Cancer Pharma Co. Dodges Investor Stock-Drop Suit
- Ex-Judge Wants Grand Jury Info On Rockefeller U. Sex Abuser
- Texas Could Take Page From Mass.'s Judicial Selection Book
- 7th Circ. Ends Insurer's RICO Suit In Testosterone MDL
- Spinal Implant Maker Files Ch. 11 Over Development Debt
- A Possible USPTO Solution To PTAB Constitutionality Ruling
- Hemp Industry Warns USDA Its THC Test Plans Are Impossible
- Wholesale Deals Can't Nix J&J Antitrust Row, 3rd Circ. Told
- Jones Day Picks Up Ex-SDNY Fraud Unit Co-Chief In NY
- FDA's Special Treatment Of Big Tech Faces Mounting Scrutiny
- Genetic Testing Gold Rush Gives Rise To Fraud Allegations
- Revised USPTO Trial Practice Guide Leans Pro-Patent Owners
- Kirkland Helps SK Capital Clinch PE Fund With $400M In Tow
- Judging A Book: McKeown Reviews 'Conversations With RBG'
- Legislative Trends May Kill Texas Employer Cannabis Tests
- Opioid Co. Inks $1.6M Deal To End Suit Over FDA Rejection
- MVP: Venable's Christopher P. Borello
- Mass. Pot Board Largely Preserves State Ban On Weed Vapes
- Law360 MVP Awards Go To Top Attorneys From 76 Firms
- Pradaxa User's Labeling Claims Preempted, Calif. Judge Rules
- E-Cig Co. Must Face Youth Marketing Suit In State Court
- DC Circ. Asks If HHS Had Leeway For Drug Payment Cuts
- Medical Pot Vapers Ask Mass. High Court To Let Ban Lapse
- CDC Finds Vitamin E Link To Vaping Lung Illnesses
- Dr. Reddy's Can't Kill Arthritis Drug Patent Suit Yet
- Utah Agrees To Drop Partial Ban On Flavored Vapes
- Noteworthy Changes From FDA's Latest Software Guidance
- Chinese Startups, US Biotechs Price IPOs Raising $121M
- 5 Things Cannabis Biz Attorneys Should Know About Tax Law
- Citizen Petitions Are Crucial In Managing A Drug's Life Cycle
- Taxation With Representation: Shearman, Skadden, Pillsbury
- Full Fed. Circ. Won't Rehear Venue Dispute In UT Patent Case
- States' Vaping Bans Face Legal Hurdles
- Sparks Fly In Opioid MDL As Judge, Attys Debate Next Trials
- NY AG's Trial Against Opioid Makers Scheduled For January
- Fed. Circ. Weighs Bid To Finish Off Pfizer Vaccine Patent
- Biogen Owes $6M For Firing Over FCA Reporting, Sex Bias
- Pot Cos. Ask 10th Circ. To Weigh Tax Case In Summons Row
- Pharma Supplier Inks $22M Deal With DOJ Over Inflated Prices
- Insurer Fights Claims Over Cryotherapy Injury Coverage
- Developments In State Taxation Of Nonadmitted Insurance
- Achillion Investor Seeks To Halt $930M Pharma Tie-Up
- Juul Pulls Mint Flavor From Market
- Gene Editing Co. Nabs $100M From Private Investors
- Calif. Privacy Law Compliance Strategies For Health Care Cos.
- Biotech Firms, Crypto Bank Raise $156M In Low-Pricing IPOs
- All Work, No Pay: HHS Sues Gilead Over HIV-Prevention IP
- Biopharma Firm Urges Chancery To Ax Cholesterol Drug Suit
- Rhode Island Flavored Vape Ban Will Stay In Effect For Now
- No Class Cert. Redo For ADHD Drug Buyers In Antitrust Suit
- Novartis Unit's Supplement Loaded With Aluminum, Suit Says
- 23AndMe Urges Full Fed. Circ. To Rethink DNA Patent Ruling
- Fed. Circ. Takes Issue With Hospira's 11th-Hour Arguments
- Purdue Opioid Suits Put On Hold Until April
- Wolf Haldenstein Tapped To Lead Curaleaf Stock Drop Suit
- Abbott Scores Win In Ex-Researcher's Retaliation Suit
- FTC Orders Prosthetic Maker To Unwind Merger
- Feds Ordered To Hand Over Docs To Ex-Theranos CEO
- Insys Creditors Say Liquidation Would Spark Chaos
- Where A Litigator's Advice Can Improve Agreement Drafting
- Industrial Hemp Could Save American Agriculture
- VC Firm Launches CA$200M Pool For Life Science Cos.
- Opioid MDL Judge Draws Fresh Fire From Pharmacies
- High Court Urged To Review Ruling Killing 2 Vimovo Patents
- Justices Should Allow Time-Bar Ruling Appeals, Biotech Says
- Mass. Board To Decide If Vape Ban Applies To Medical Pot
- Supplement Maker Hid Illegal Stimulant, Consumers Say
- Coloplast Sets Aside $60M For Surgical Mesh Litigation Costs
- Cannabis-Focused Blank Check Co. Prices Upsized $120M IPO
- M&A 'Pure Omission' Claims Test Limits Of Securities Laws
- 2nd Circ. Won't Revive Antitrust Suit Over Cancer Drugs
- New Calif. Pay-For-Delay Law May Hurt Those It Aims To Help
- Fed. Circ. Offers Obviousness-Type Double Patenting Cure
- Ex-Theranos CEO Claims FDA Destroyed Key Evidence
- Ballot Measure Can't Legalize Pot, Fla. Legislators Say
- Insys Ch. 11 Disclosures Draw Fire From DOJ, US Trustee
- ITC To Investigate Medical Device Imports
- Arthrex Seeks 2nd PTAB Redo After Constitutionality Ruling
- Mass. Top Court To Hear Argument Over State's Vaping Ban
- Imerys Asks For $1.3M To Motivate Workers During Ch. 11
- How To Drop A Client Ignoring Your Bills: 3 Cases To Know
- Supreme Court Passes On TWC Appeal, 4 Other Patent Cases
- Care.com Wants Investors' Background Check Suit Tossed
- Adapting To FDA's Proposal For Diagnosis Support Software
- Flat-Fee Legal Billing Can Liberate Attorneys
- 15 Minutes With Bausch Health's General Counsel
- 2 Firms Grab Lion's Share Of IPOs In Shaky October
- Skadden Guides Stryker's $4B Deal For Wright Medical
- Surveying The Fallout From The PTAB Constitutionality Ruling
- Ex-Fed. Circ. Judge Decries 'Fundamental Rift' Over Eligibility
- Warren Medicare Plan May Downplay Economic Impact Of Tax
- 16 Firms To Steer 9 IPOs Led By Canadian Co.'s $1.9B Offering
- Insys MDL Group Slams Del. Ch. 11 Doc As Fatally Flawed
- Fla. Fentanyl Dealer Sentenced To 30 Years Behind Bars
- Pa. Doctor To Pay $1.4M To Settle Opioid Prescription Claims
- Indiana Asks 7th Circ. To Reconsider 'Smokable Hemp' Ban
- Seroquel XR Suits Belong In Delaware, AstraZeneca Says
- Praxair Says Recent Ruling Won't 'Devastate' Medical Patents
- Spoliation Rule Remains Ambiguous Despite Amendments
- Deals Rumor Mill: Saudi Aramco, Bitmain, Alibaba
- Assessing USDA Hemp Rule's Impact On Cannabis IP
- Calif. Court Revives Veeva's Push To Void Noncompetes
- Trump Taps Cancer Doc To Lead FDA
- Health Hires: King & Spalding, Arnold & Porter
- Warren Wants Cos., The Rich To Pay For $20.5T Medicare Plan